Buyer Consortium Extends Deadline for HollySys Shareholders to Submit Consents to August 20, 2021
- Wall Street surges to all-time closing high on earnings, economic revival
- Was Intel's (INTC) Second Quarter a Speedbump or Inflection?
- Twitter (TWTR) Gains After Beating Q2 Estimates, Analysts Raise PTs as Brand Recovery Accelerates
- U.S. dollar on track for second week of gains; Fed meeting in focus
- Snap (SNAP) Surges 17% After Smashing Q2 Views Across the Board to Yield a Dozen Price Target Hikes
News and research before you hear about it on CNBC and others. Claim your 1-week free trial to StreetInsider Premium here.
BEIJING--(BUSINESS WIRE)-- The buyer consortium (the “Consortium”) consisting of Mr. Shao Baiqing, Ace Lead Profits Limited and CPE Funds Management Limited today announces the extension of the deadline by which shareholders of Hollysys Automation Technologies Ltd. (NASDAQ: HOLI) (the “Company”) may submit consents to the Consortium’s proposed resolutions concerning its proposed acquisition of all outstanding ordinary shares of the Company not already owned by the Consortium at a price of $17.10 per share in cash. The Company’s shareholders are now cordially asked to sign, date and return the WHITE consent card or otherwise submit their consents as soon as possible, but in any event on or before August 20, 2021.
The decision to extend the deadline for submitting consents is primarily prompted by inquiries from shareholders who wish to know the outcome of the ongoing litigation before the British Virgin Islands Court (the “Court”) concerning the legality of the Company’s amendments to its memorandum and articles of association, hastily passed by the Company’s board of directors and without shareholders’ approval, on January 7, 2021. As the Court has not handed down its judgment, the Consortium will extend the deadline for submission to August 20, 2021, which may be further extended if the Court judgment for this litigation is not available at that time.
In further response to shareholder inquiries, the Consortium states the following regarding the Company’s July 15, 2021 press release:
“The Consortium is aware of the press release by the Company on July 15, 2021, with the misleading title “HollySys Sets Record Straight on Consortium’s Consent Solicitation” (the “July 15 Press Release”). We do not agree with the July 15 Press Release. It should be noted that many of the issues raised in the July 15 Press Release are currently being scrutinised before the Court, and the Consortium believes that the July 15 Press Release is disrespectful to the Court whilst it deliberates on the proceedings, and irresponsible and misleading to the Company’s shareholders. Accordingly, and to show the necessary respect to the Court as any sensible persons should, it is the Consortium’s decision not to make any further comment on the July 15 Press Release until judgment is handed down by the Court. Once a judgment is handed down, the Consortium will make an announcement for the purpose of, among other things, responding to the July 15 Press Release.”
Shareholders owning shares through a bank or broker (i.e., in “street-name” or as a “beneficial owner”) who have not yet received the Consortium’s consent materials should promptly contact their bank or broker and request instructions regarding the WHITE consent card. Shareholders with questions about how to submit consents and related matters should promptly contact Innisfree M&A Incorporated, the firm assisting the Consortium with the consent solicitation, by email at HOLIconsent@innisfreema.com or by phone at +1 (877) 750-9501 (toll-free from the U.S. and Canada), or at +1 (412) 232-3651 (from other locations), during the hours of 10:00 a.m.-7:00 p.m. Eastern Time, Monday-Friday, and 10:00 a.m.-2:00 p.m. Eastern Time on Saturdays.
CPE Funds Management Limited
Source: CPE Funds Management Limited
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Anthem, Inc. Invests in Nearly $90 Million in Affordable Housing in Indiana as part of Commitment to Improving Lives and Communities
- Allegro Ophthalmics Announces Positive Results of Vehicle-controlled Ex-U.S. Phase 2 Trial of ALG-1007 for the Treatment of Dry Eye Disease
- Seadrill Limited (SDRL) - Agreement with Stakeholders to raise $350 million and reduce liabilities by approximately $5 billion
Create E-mail Alert Related CategoriesBusiness Wire, Press Releases
Related EntitiesDefinitive Agreement
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!